These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 311530)

  • 21. Platelet-binding of the von Willebrand factor.
    Green D; Muller HP
    Thromb Haemost; 1978 Jun; 39(3):689-94. PubMed ID: 309191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of inhibition by trinitrophenylation of the ristocetin cofactor activity of von Willebrand factor.
    Santoro SA; Cowan JF
    Biochim Biophys Acta; 1984 Feb; 797(2):178-85. PubMed ID: 6607747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody to human factor VIII/von Willebrand factor inhibits collagen-induced platelet aggregation and release.
    Tschopp TB; Baumgartner HR; Meyer D
    Thromb Res; 1980 Jan 1-15; 17(1-2):255-9. PubMed ID: 6769178
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibitory effect of ristocetin and factor VIII/von Willebrand factor protein on human platelet adenylate cyclase activity.
    Kao KJ; Tsai BS; McKee PA; Lefkowitz RJ; Pizzo SV
    Thromb Res; 1983 May; 30(3):301-8. PubMed ID: 6408756
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of Willebrand factor in von Willebrand disease.
    Maragall S; Castillo R; Ordinas A; Liendo F; Rodríguez M
    Thromb Res; 1979; 14(2-3):495-500. PubMed ID: 312541
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of the quantitative ristocetin von Willebrand factor assay by using fresh and fixed platelets.
    Kelton JG; Bishop J; Carter CJ; Hirsh J
    Thromb Res; 1980 May 1-15; 18(3-4):477-83. PubMed ID: 6968105
    [No Abstract]   [Full Text] [Related]  

  • 27. Species specificity in von Willebrand factor-supported platelet agglutination.
    Johnson GS; Dodds WJ; Rosborough TK
    Ann N Y Acad Sci; 1981; 370():227-35. PubMed ID: 6973945
    [No Abstract]   [Full Text] [Related]  

  • 28. Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor.
    Takahashi H; Shibata A
    Thromb Haemost; 1984 Dec; 52(3):267-70. PubMed ID: 6241752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.
    Jenkins CS; Phillips DR; Clemetson KJ; Meyer D; Larrieu MJ; Lüscher EF
    J Clin Invest; 1976 Jan; 57(1):112-24. PubMed ID: 1081991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolated recombinant domain of von Willebrand factor displaying increased sensitivity to ristocetin.
    Hayashi T; Ware J; Niiya K; Sakuragawa N
    Am J Hematol; 1996 Aug; 52(4):248-53. PubMed ID: 8701941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Von Willebrand factor dependent platelet aggregation and adsorption of factor VIII related antigen by collagen.
    Nyman D
    Thromb Res; 1980 Jan 1-15; 17(1-2):209-14. PubMed ID: 6154982
    [No Abstract]   [Full Text] [Related]  

  • 32. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
    N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet-type von Willebrand disease platelet aggregating factor: a novel functional assay of von Willebrand factor.
    Takahashi H; Tatewaki W; Hanano M; Shibata A
    Thromb Res; 1987 Nov; 48(4):475-85. PubMed ID: 3127926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human platelet membrane receptor for bovine von Willebrand factor (platelet aggregating factor): an integral membrane glycoprotein.
    Cooper HA; Clemetson KJ; Lüscher EF
    Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1069-73. PubMed ID: 312498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variant forms of von Willebrand's disease: type IIA, type IIB and platelet-type von Willebrand's disease.
    Takahashi H
    Nihon Ketsueki Gakkai Zasshi; 1984 Dec; 47(8):1678-89. PubMed ID: 6335811
    [No Abstract]   [Full Text] [Related]  

  • 36. Membrane fluidity and platelet aggregation: dibucaine permits ristocetin-induced platelet aggregation with low-molecular-weight von Willebrand multimers.
    Gjønnaess E; Solum NO; Brosstad F
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):395-405. PubMed ID: 1420815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identity of bovine platelet aggregation factor and ristocetin-Willebrand factor.
    Kalogjera V; Owen WG
    Thromb Res; 1978 Nov; 13(5):857-64. PubMed ID: 311087
    [No Abstract]   [Full Text] [Related]  

  • 38. Ristocetin-Willebrand factor activity in dog plasma.
    Johnstone IB; Lotz F
    Can J Physiol Pharmacol; 1980 Sep; 58(9):1128-34. PubMed ID: 6970064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
    N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of vancomycin on ristocetin and bovine PAF-induced agglutination of human platelets.
    Baugh RF; Jacoby C; Brown JE; Hougie C
    Thromb Res; 1978 Mar; 12(3):511-21. PubMed ID: 306689
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.